On April 19, 2005, the Canadian government gave conditional
approval to prescription sale of a medicine made
from extracts of marijuana plants ingested as an oral spray.
While the US blocked privately-funded research, a British
pharmaceutical company developed a cannabis extract
spray that supplements existing non-smoking delivery systems
such as vaporization.
The risks versus the benefits of alternative methods need to
be established. But the US government is obstructing
the science1 because it fears the
an acceptable risk/benefit ratio even for smoked marijuana.
This research would be welcomed by the 14,600,0002
Americans who currently use marijuana socially or medically.
It is time our officials take off their "drug war" blinders and
recognize marijuana for what it is: a natural, relatively
benign substance that can help bring relief to millions.